Biologics

Gurtej Singh, MD, a physical medicine and rehabilitation physician, connected with Becker's to answer, "Are orthobiologics overhyped?"

Aziyo Biologics is recalling its viable bone matrix products after two patients were infected with Mycobacterium tuberculosis following surgeries, the orthobiologics company said July 13.

The first four surgeries using the EnFix RC fiber implant for rotator cuff repair were completed at Rush Oak Brook (Ill.) Surgery Center.

The Biden administration launched a program under the Advanced Research Projects Agency for Health focused on orthopedic tissue regeneration.

Here are five developments in orthobiologics to know since April 1:

Royal Biologics launched its Bio-Reign 3D bone graft substitute, the company said May 23.

Creative Medical Technology Holdings' StemSpine procedure was found to be effective in treating chronic lower back pain, according to a pilot study.

Bioventus sold its wound care segment to LifeNet Health, according to a May 10 news release.

OssDesign's Catalyst nanosynthetic bone graft has been used in 1,000 patients, the medtech company said May 9.

Bioventus' CEO Ken Reali left his post on April 4.